Current Drug Discovery Technologies

Vladimir P. Torchilin
Department of Pharmaceutical Science Center
for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115



Become EABM
Become Reviewer

Editorial [Hot Topic:Advances in Integration of Cheminformatics & Bioinformatics Special Issue (Editor: Petr Kocis)] promotion: free to download

Volume:2   Issue: 2
Pp: 53-53
Petr Kocis
DOI: 10.2174/1570163054064710

QSAR Modeling of Carcinogenic Risk Using Discriminant Analysis and Topological Molecular Descriptors

Volume:2   Issue: 2
Pp: 55-67
Joseph F. Contrera, Philip MacLaughlin, Lowell H. Hall and Lemont B. Kier
DOI: 10.2174/1570163054064684

Exploration Tools for Drug Discovery and Beyond: Applying SciFinder® to Interdisciplinary Research

Volume:2   Issue: 2
Pp: 69-74
Margaret Haldeman, Barbara Vieira, Fred Winer and Lars J. S. Knutsen
DOI: 10.2174/1570163054064693

New Approaches to Mechanism Analysis for Drug Discovery Using DNA Microarray Data Combined with KeyMolnet

Volume:2   Issue: 2
Pp: 89-98
Hiromi Sato, Seiichi Ishida, Kyoko Toda, Rieko Matsuda, Yuzuru Hayashi, Makoto Shigetaka, Miki Fukuda, Yohko Wakamatsu and Akiko Itai
DOI: 10.2174/1570163054064701

Comprehensive Computational Assessment of ADME Properties Using Mapping Techniques

Volume:2   Issue: 2
Pp: 99-113
Konstantin V. Balakin, Yan A. Ivanenkov, Nikolay P. Savchuk, Andrey A. Ivashchenko and Sean Ekins
DOI: 10.2174/1570163054064666